Figure 2From: Hepatic iron overload, a possible consequence of treatment with imatinib mesylate: a case reportHepatic hemosiderosis is a likely consequence of imatinib treatment. Liver biopsy with iron stain revealing prominent iron deposition within hepatic parenchymal cells and portal areas (indicated).Back to article page